| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 91.3 | 68.0 |
| Gross profit | 69.3 | 45.1 |
| Profit before tax | 6.6 | -3.2 |
| Net income | 6.6 | -3.2 |
| EPS (diluted, $ a share) | $0.10 | $-0.06 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +34.2% |
|---|---|
| Gross margin | 75.9% |
| Operating margin | 5.3% |
10-Q filed with the SEC, NASDAQ: OMDA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Omada Health, Inc.: key numbers
- Share price
- $14.49Close, Nov 16
- Market cap
- $899M
- Shares outstanding
- 62.04MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Omada Health, Inc.
All →Omada Health CEO Sean P. Duffy Sells $249K of Stock
Sean P. Duffy, CEO, sold 12,944 shares of Omada Health, Inc. at $19.22 a share, worth $249K in total on Nov 4, 2026. Shares held after the trade: 382,594 (-3.3%).
- Value
- $249K
- Shares
- 12,944
- Price
- $19.22
- Role
- CEO
- Holding change
- -3.3%
- Trade date
- Nov 4, 2026
Omada Health Financial Results
Omada Health reported Q3 2026 revenue of $91 million, a 34% year-over-year increase, and reached a record 1.1 million total members. The company achieved GAAP net income of $7 million compared to a loss in the prior year and raised its full-year 2026 revenue and Adjusted EBITDA guidance.
- Term
- Q3 2026
“Omada Health delivered its strongest quarter yet, with revenue growing 34% year over year, Total Members increasing 36% and a GAAP gross margin of 76%. Our diabetes and hypertension programs led that growth, and average tenure in our programs reached a record of roughly two years and four months. That gives members more time to build lasting habits and the confidence to manage their health.”
Sean Duffy, co-founder and CEO of Omada Health
Omada Health CEO Sean P. Duffy Sells $357K of Stock
Sean P. Duffy, CEO, sold 17,258 shares of Omada Health, Inc. at $20.61 to $20.90 a share (average $20.68) in 2 transactions, worth $357K in total on Oct 1, 2026. Shares held after the trade: 382,594 (-1.1%).
- Value
- $357K
- Shares
- 17,258
- Average price
- $20.68
- Role
- CEO
- Holding change
- -1.1%
- Trade date
- Oct 1, 2026
Omada Health CEO Sean P. Duffy Sells $327K of Stock
Sean P. Duffy, CEO, sold 14,960 shares of Omada Health, Inc. at $21.80 to $22.59 a share (average $21.87) in 2 transactions, worth $327K in total on Sep 10, 2026. Shares held after the trade: 382,594 (-0.4%).
- Value
- $327K
- Shares
- 14,960
- Average price
- $21.87
- Role
- CEO
- Holding change
- -0.4%
- Trade date
- Sep 10, 2026
Omada Health CFO Steven L. Cook Sells $149K of Stock
Steven L. Cook, CFO, sold 6,800 shares of Omada Health, Inc. at $21.80 to $22.52 a share (average $21.86) in 2 transactions, worth $149K in total on Sep 10, 2026. Shares held after the trade: 173,906 (-0.3%).
- Value
- $149K
- Shares
- 6,800
- Average price
- $21.86
- Role
- CFO
- Holding change
- -0.3%
- Trade date
- Sep 10, 2026
Omada Health President Wei-Li Shao Sells $79.2K of Stock
Wei-Li Shao, President, sold 3,636 shares of Omada Health, Inc. at $21.78 a share, worth $79.2K in total on Sep 10, 2026. Shares held after the trade: 295,713 (-1.2%).
- Value
- $79.2K
- Shares
- 3,636
- Price
- $21.78
- Role
- President
- Holding change
- -1.2%
- Trade date
- Sep 10, 2026